MaxCyte, Inc. Files 8-K Report
Ticker: MXCT · Form: 8-K · Filed: Jun 25, 2025 · CIK: 1287098
Sentiment: neutral
Topics: 8-K, disclosure, financials
Related Tickers: MXCT
TL;DR
MaxCyte filed an 8-K on 6/25/25, likely with financial updates.
AI Summary
On June 25, 2025, MaxCyte, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and significant occurrences. No specific financial figures or new material events were detailed in the provided excerpt.
Why It Matters
This 8-K filing signals that MaxCyte, Inc. has made a regulatory disclosure, which could contain important updates for investors regarding the company's operations or financial condition.
Risk Assessment
Risk Level: low — The filing is a standard 8-K disclosure without immediate indication of significant negative events or financial distress.
Key Players & Entities
- MAXCYTE, INC. (company) — Registrant
- June 25, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Rockville, Maryland (location) — Address of principal executive offices
FAQ
What is the primary purpose of this 8-K filing for MaxCyte, Inc.?
The filing is for "Other Events" and "Financial Statements and Exhibits," indicating disclosures related to significant company occurrences and financial information.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 25, 2025.
Where are MaxCyte, Inc.'s principal executive offices located?
MaxCyte, Inc.'s principal executive offices are located at 9713 Key West Avenue, Suite 400, Rockville, Maryland.
What is MaxCyte, Inc.'s state of incorporation?
MaxCyte, Inc. is incorporated in Delaware.
What is the SEC file number for MaxCyte, Inc.?
The SEC file number for MaxCyte, Inc. is 001-40674.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 25, 2025 regarding MAXCYTE, INC. (MXCT).